Randomized Controlled Trial
doi: 10.1016/j.fertnstert.2014.07.1251.
Epub 2014 Sep 17.
RETRACTED: Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial
Affiliations
- PMID: 25241364
- DOI: 10.1016/j.fertnstert.2014.07.1251
Item in Clipboard
Randomized Controlled Trial
RETRACTED: Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial
Fertil Steril.
2014 Nov.
Free article
Retraction in
-
Retraction notice to "Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial".Fertil Steril. 2023 Mar;119(3):518. doi: 10.1016/j.fertnstert.2023.02.001. Fertil Steril. 2023. PMID: 36863806 No abstract available.
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the ASRM Publications Committee. The Committee reviewed concerns related to the accuracy of data reported in Table 2 and the authors acknowledged significant errors that could not be corrected because they were unable to provide the original data. As the Committee cannot vouch for the accuracy of the data, we have issued a retraction of this article.
Keywords: Recurrent pregnancy loss; Th1 cytokines; Th2 cytokines; dydrogesterone; pregnancy outcome.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.J Matern Fetal Neonatal Med. 2005 Oct;18(4):265-9. doi: 10.1080/14767050500246243. J Matern Fetal Neonatal Med. 2005. PMID: 16318978 Clinical Trial.
-
A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.Trials. 2016 Aug 17;17(1):408. doi: 10.1186/s13063-016-1509-8. Trials. 2016. PMID: 27534747 Free PMC article. Clinical Trial.
-
Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage.BJOG. 2005 Aug;112(8):1096-101. doi: 10.1111/j.1471-0528.2005.00633.x. BJOG. 2005. PMID: 16045524 Clinical Trial.
-
The role of dydrogesterone in recurrent (habitual) abortion.J Steroid Biochem Mol Biol. 2005 Dec;97(5):426-30. doi: 10.1016/j.jsbmb.2005.08.009. Epub 2005 Sep 26. J Steroid Biochem Mol Biol. 2005. PMID: 16188436 Review.
-
Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.Fertil Steril. 2017 Feb;107(2):430-438.e3. doi: 10.1016/j.fertnstert.2016.10.031. Epub 2016 Nov 22. Fertil Steril. 2017. PMID: 27887710 Review.
Cited by
-
Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.Singapore Med J. 2017 Jun;58(6):294-297. doi: 10.11622/smedj.2016080. Epub 2016 Apr 19. Singapore Med J. 2017. PMID: 27090598 Free PMC article.
-
Cytokines, Hormones and Cellular Regulatory Mechanisms Favoring Successful Reproduction.Front Immunol. 2021 Jul 28;12:717808. doi: 10.3389/fimmu.2021.717808. eCollection 2021. Front Immunol. 2021. PMID: 34394125 Free PMC article. Review.
-
Prevention of Pregnancy Loss: Combining Progestogen Treatment and Psychological Support.J Clin Med. 2023 Feb 24;12(5):1827. doi: 10.3390/jcm12051827. J Clin Med. 2023. PMID: 36902614 Free PMC article. Review.
-
The maternal drug exposure birth cohort (DEBC) in China.Nat Commun. 2024 Jun 21;15(1):5312. doi: 10.1038/s41467-024-49623-0. Nat Commun. 2024. PMID: 38906856 Free PMC article.
-
Progesterone promotes maternal-fetal tolerance by reducing human maternal T-cell polyfunctionality and inducing a specific cytokine profile.Eur J Immunol. 2015 Oct;45(10):2858-72. doi: 10.1002/eji.201445404. Epub 2015 Aug 28. Eur J Immunol. 2015. PMID: 26249148 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
